| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7133581
[patent_doc_number] => 20040043037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Staphylococcus aureus polynucleotides and sequences'
[patent_app_type] => new
[patent_app_number] => 10/329624
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 60152
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10329624
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/329624 | Staphylococcus aureus polynucleotides and sequences | Dec 26, 2002 | Abandoned |
Array
(
[id] => 6633998
[patent_doc_number] => 20030211518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods'
[patent_app_type] => new
[patent_app_number] => 10/321953
[patent_app_country] => US
[patent_app_date] => 2002-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18089
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10321953
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/321953 | Methods for identifying and monitoring patients at risk for systemic inflammatory conditions, methods for selecting treatments for these patients and apparatus for use in these methods | Dec 16, 2002 | Issued |
Array
(
[id] => 6829762
[patent_doc_number] => 20030180820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Tests for the rapid evaluation of ischemic states and kits'
[patent_app_type] => new
[patent_app_number] => 10/319263
[patent_app_country] => US
[patent_app_date] => 2002-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 23231
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180820.pdf
[firstpage_image] =>[orig_patent_app_number] => 10319263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/319263 | Tests for the rapid evaluation of ischemic states and kits | Dec 12, 2002 | Issued |
Array
(
[id] => 6660153
[patent_doc_number] => 20030134797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Treating eye disorders using intestinal trefoil proteins'
[patent_app_type] => new
[patent_app_number] => 10/313642
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13715
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10313642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/313642 | Treating eye disorders using intestinal trefoil proteins | Dec 5, 2002 | Abandoned |
| 10/149865 | Reagents, methods and kits for detecting bacillus thuringiensis proteins | Dec 1, 2002 | Abandoned |
Array
(
[id] => 6851557
[patent_doc_number] => 20030143760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications'
[patent_app_type] => new
[patent_app_number] => 10/308150
[patent_app_country] => US
[patent_app_date] => 2002-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11105
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20030143760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10308150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/308150 | Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications | Dec 1, 2002 | Abandoned |
Array
(
[id] => 6766085
[patent_doc_number] => 20030100485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Human neurotrimin homolog'
[patent_app_type] => new
[patent_app_number] => 10/306133
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20614
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306133 | Human neurotrimin homolog | Nov 26, 2002 | Abandoned |
Array
(
[id] => 7173947
[patent_doc_number] => 20050203280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/501282
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 304749
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501282 | Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof | Nov 24, 2002 | Abandoned |
Array
(
[id] => 6701116
[patent_doc_number] => 20030223996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Antibodies that immunospecifically bind to BLyS'
[patent_app_type] => new
[patent_app_number] => 10/293418
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 188019
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20030223996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10293418
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/293418 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Nov 13, 2002 | Issued |
Array
(
[id] => 6678169
[patent_doc_number] => 20030228309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors'
[patent_app_type] => new
[patent_app_number] => 10/292486
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 172308
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228309.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292486 | Antibodies that immunospecifically bind to TRAIL receptors | Nov 12, 2002 | Abandoned |
Array
(
[id] => 6856132
[patent_doc_number] => 20030129633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'DNA replication proteins of Gram positive bacteria and their use to screen for chemical inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/282287
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26087
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10282287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/282287 | Isolated staphylococcus DNAX subunit and use thereof | Oct 27, 2002 | Issued |
Array
(
[id] => 6856132
[patent_doc_number] => 20030129633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'DNA replication proteins of Gram positive bacteria and their use to screen for chemical inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/282287
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26087
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129633.pdf
[firstpage_image] =>[orig_patent_app_number] => 10282287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/282287 | Isolated staphylococcus DNAX subunit and use thereof | Oct 27, 2002 | Issued |
| 10/274586 | Critical genes and polypeptides of haemophilus influenzae and methods of use | Oct 20, 2002 | Abandoned |
Array
(
[id] => 6843602
[patent_doc_number] => 20030148949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Methods and compositions for treating dermal lesions'
[patent_app_type] => new
[patent_app_number] => 10/266069
[patent_app_country] => US
[patent_app_date] => 2002-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7128
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10266069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/266069 | Methods and compositions for treating dermal lesions | Oct 6, 2002 | Abandoned |
Array
(
[id] => 7446287
[patent_doc_number] => 20040067239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/263153
[patent_app_country] => US
[patent_app_date] => 2002-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 23673
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10263153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/263153 | Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof | Oct 1, 2002 | Issued |
Array
(
[id] => 6797778
[patent_doc_number] => 20030176652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Human and mouse beta-defensins, antimicrobial peptides'
[patent_app_type] => new
[patent_app_number] => 10/252734
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 32527
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176652.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252734 | Human and mouse beta-defensins, antimicrobial peptides | Sep 22, 2002 | Abandoned |
Array
(
[id] => 6787733
[patent_doc_number] => 20030138972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-24
[patent_title] => 'Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications'
[patent_app_type] => new
[patent_app_number] => 10/247853
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12442
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20030138972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247853 | Monoclonal antibodies specific PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications | Sep 19, 2002 | Abandoned |
Array
(
[id] => 6870044
[patent_doc_number] => 20030082733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/246976
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 41217
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246976
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246976 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 17, 2002 | Abandoned |
Array
(
[id] => 5720359
[patent_doc_number] => 20060073133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Sialoadhesin factor-3 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/246019
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19488
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073133.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246019 | Sialoadhesin factor-3 antibodies | Sep 17, 2002 | Abandoned |
Array
(
[id] => 6683279
[patent_doc_number] => 20030119143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/247036
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 116
[patent_no_of_words] => 45003
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119143.pdf
[firstpage_image] =>[orig_patent_app_number] => 10247036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/247036 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Sep 17, 2002 | Abandoned |